# AstraZeneca is planning to sell its 64-acre manufacturing facility in North Bengaluru.

*business · news · 2026-04-09 · The Economic Times*

## Key points

- AstraZeneca Pharma India plans to sell its 64-acre North Bengaluru manufacturing facility.
- The land sale is part of AstraZeneca's global manufacturing and supply network review.
- Sattva Group, Aurobindo Pharma, and RMZ have been shortlisted as potential buyers.
- AstraZeneca now seeks a full exit, allowing for commercial and residential redevelopment.

**Companies:** AstraZeneca, Aurobindo Pharma, Sattva Group, RMZ
**Countries:** India, United Kingdom

[Read the full story on The Economic Times](https://economictimes.indiatimes.com/industry/indl-goods/svs/construction/astrazeneca-india-plans-to-sell-64-acre-bengaluru-site-for-rs-3400-crore/articleshow/130153261.cms)

---

Canonical: https://newsio.io/n/0475450a-fd20-4f19-b8ff-8477c2792219/astrazeneca-is-planning-to-sell-its-64-acre-manufacturing-facility-in-north-beng
Summarized by Newsio from The Economic Times. https://newsio.io/how-it-works